Dose-Response Relationship, RadiationBrachytherapyUltraviolet RaysRadiation InjuriesRadiotherapy DosageNuclear EnergyRadiation DosageRadioisotope TeletherapyCombined Modality TherapyRadiotherapyProstateNeoplasmsRadiation MonitoringNeoplasms, Radiation-InducedNuclear ReactorsProstatic NeoplasmsRadiotherapy, ConformalThyroid NeoplasmsRadiation, IonizingRadiotherapy, AdjuvantIodine RadioisotopesCarcinogensNuclear WarfareRadiotherapy, Intensity-ModulatedRadioactive FalloutRadiometryProstate-Specific AntigenTreatment OutcomeAir Pollution, RadioactiveRetrospective StudiesKazakhstanRadiation ToleranceRadiotherapy Planning, Computer-AssistedRadiation OncologyDose FractionationCell Transformation, NeoplasticAneuploidyRadioisotopesRadiationRadiotherapy, High-EnergyCell Line, TumorRisk AssessmentNeoplasm StagingAndrogen AntagonistsNeoplasm Recurrence, LocalRadiation ProtectionRisk FactorsRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedProstatectomyBreast NeoplasmsReceptors, AndrogenAndrogensAdenocarcinomaRadiation PneumonitisRadiosurgeryPrognosisSurvival RateSurvival AnalysisNeoplasm MetastasisLung NeoplasmsEarly Detection of CancerAntineoplastic Combined Chemotherapy ProtocolsGene Expression Regulation, NeoplasticFollow-Up StudiesRadiation-Sensitizing AgentsHead and Neck NeoplasmsAntineoplastic AgentsDisease-Free SurvivalMice, NudeCarcinoma, Squamous CellOccupational ExposureBrain NeoplasmsDisease ProgressionTumor Markers, BiologicalNeoplasm InvasivenessBone NeoplasmsNeoplasms, Hormone-DependentProstatic HyperplasiaChemotherapy, AdjuvantParticle AcceleratorsOrchiectomyCranial IrradiationCarcinomaChemoradiotherapyOrgans at RiskTime FactorsRectal NeoplasmsRadiation Injuries, ExperimentalTumor BurdenProspective StudiesGamma RaysCisplatinXenograft Model Antitumor AssaysApoptosisNeoplasm GradingAntineoplastic Agents, HormonalTomography, X-Ray ComputedRadiodermatitisCarcinoma, Non-Small-Cell Lung